![]() |
市場調查報告書
商品編碼
1463757
歐洲鳳梨蛋白酶市場預測至 2030 年 - 區域分析 - 按來源(莖和水果)和應用(食品和飲料、藥品和保健品、個人護理等)Europe Bromelain Market Forecast to 2030 - Regional Analysis - by Source (Stem and Fruit) and Application (Food & Beverages, Pharmaceuticals & Nutraceuticals, Personal Care, and Others) |
2022年歐洲鳳梨蛋白酶市場價值為1,172萬美元,預計到2030年將達到2,079萬美元;預計 2022 年至 2030 年CAGR為 7.4%。
製藥和保健品行業應用的增加推動了歐洲鳳梨蛋白酶市場
鳳梨蛋白酶在製藥工業中用作抗腫瘤、抗發炎和抗血栓形成劑。而且還能預防支氣管炎、鼻竇炎、血栓性靜脈炎等疾病。人們對其血小板聚集抑制、抗水腫、抗血栓和纖溶活性進行了研究。它也因其幫助消化和促進傷口癒合的能力而聞名。由於這些治療作用,它被廣泛用於藥物配方和保健品。人們越來越關注保持最佳消化和腸道健康,這增加了膳食補充劑生產中對鳳梨蛋白酶的需求。
鳳梨蛋白酶也用於治療受傷或手術後鼻子和鼻竇的發炎和腫脹。鳳梨蛋白酶的抗發炎和鎮痛特性使其能夠有效治療與骨關節炎相關的疼痛、軟組織腫脹和關節僵硬。鳳梨蛋白酶可改善功能並減輕輕微急性膝蓋疼痛和骨關節炎的疼痛。根據世界衛生組織(WHO) 的數據,2019 年全球有近5.28 億人患有骨關節炎,自1990 年以來增加了113%。了市場的成長。
歐洲鳳梨蛋白酶市場概況
歐洲鳳梨蛋白酶市場分為德國、法國、義大利、英國、俄羅斯和歐洲其他地區。歐洲市場的成長歸因於鳳梨蛋白酶在化妝品、膳食補充劑和其他應用中的接受度不斷提高。食品和飲料行業生活方式趨勢的轉變進一步推動了該地區歐洲鳳梨蛋白酶市場的成長。在烘焙業中,鳳梨蛋白酶被用作麵團改良劑和風味增強劑。據英國麵包師聯合會稱,烘焙業是食品和飲料行業最大的細分市場之一。鳳梨蛋白酶製造商正在開發新穎的產品,以滿足食品和飲料行業日益成長的需求。例如,2021 年 8 月,比利時公司 ENZYBEL GROUP 推出了一款名為鳳梨蛋白酶 K 的新鳳梨蛋白酶產品,專為肉類嫩化、蛋白質水解劑和增味劑等食品和飲料應用而開發。
鳳梨蛋白酶在德國和其他西歐國家被廣泛用作保健補充劑,也用於治療受傷或手術後鼻子和鼻竇的發炎和腫脹。此外,鳳梨蛋白酶可以改善功能並減輕輕微急性膝痛和膝骨關節炎的疼痛。根據 Versus Arthritis 於 2023 年初發布的報告,歐洲有 1,000 萬人患有骨關節炎,估計有 540 萬人患有膝骨關節炎。骨科疾病的高發生率增加了對鳳梨蛋白酶補充劑的需求。
歐洲擁有完善的個人護理行業,是化妝品和其他個人護理產品最重要的市場之一。以鳳梨蛋白酶為基礎的美容補充劑可增強皮膚強度和彈性,從而為皮膚提供抗皺效果。以鳳梨蛋白酶為基礎的護膚產品可改善乾燥和受損皮膚的外觀,並用於治療痤瘡。該地區金融狀況的改善導致化妝品和個人護理產品的人均支出增加。根據個人護理品製造商協會Cosmetics Europe統計,2020年歐盟化妝品產業相關類別中,保養品的市場價值最為可觀。
歐洲鳳梨蛋白酶市場收入及2030年預測(千美元)
歐洲鳳梨蛋白酶市場細分
歐洲鳳梨蛋白酶市場分為來源、應用和國家。
從來源來看,歐洲鳳梨蛋白酶市場分為莖和果。 2022 年,莖細分市場將佔據更大佔有率。
從應用來看,歐洲鳳梨蛋白酶市場分為食品和飲料、藥品和保健品、個人護理等。 2022 年,食品和飲料領域佔最大佔有率。
根據國家/地區,歐洲鳳梨蛋白酶市場分為德國、法國、義大利、英國、俄羅斯和歐洲其他地區。 2022 年,歐洲其他地區主導了歐洲鳳梨蛋白酶市場。
Challenge Bioproducts Co Ltd、Creative Enzymes、Enzybel International SA 和 Medikonda Nutrients 是歐洲鳳梨蛋白酶市場上的一些領先公司。
表中的內容
The Europe bromelain market was valued at US$ 11.72 million in 2022 and is expected to reach US$ 20.79 million by 2030; it is estimated to grow at a CAGR of 7.4% from 2022 to 2030.
Increasing Applications in Pharmaceutical & Nutraceutical Industry Fuels the Europe Bromelain Market
Bromelain is used in the pharmaceutical industry as an anti-tumorigenic, anti-inflammatory, and anti-thrombotic agent. Moreover, it can prevent diseases such as bronchitis, sinusitis, and thrombophlebitis. It has been studied for its platelet aggregation inhibition, anti-edematous, anti-thrombotic, and fibrinolytic activities. It is also known for its ability to aid in digestion and wound-healing enhancement. Owing to these therapeutic actions, it is extensively used in pharmaceutical formulas and health supplements. The growing focus on maintaining optimum digestive and gut health boosts the demand for bromelain in dietary supplement manufacturing.
Bromelain is also applied in treating inflammation and swelling of the nose and sinuses after an injury or surgery. The anti-inflammatory and analgesic properties of bromelain make it an effective treatment for pain, soft tissue swelling, and joint stiffness associated with osteoarthritis. Bromelain improves functionality and decreases pain in mild acute knee pain and osteoarthritis. According to the World Health Organization (WHO), nearly 528 million people worldwide were living with osteoarthritis in 2019, recording an increase of 113% since 1990. Therefore, the rising applications of bromelain in the pharmaceutical & nutraceutical industries fuels the market growth.
Europe Bromelain Market Overview
The Europe bromelain market is segmented into Germany, France, Italy, the UK, Russia, and the Rest of Europe. The market growth in Europe is ascribed to the increasing acceptance of bromelain in cosmetics, dietary supplements, and other applications. Transforming lifestyle trends concerning the food & beverages industry further boosts the Europe bromelain market growth in the region. In the bakery industry, bromelain is used as a dough improver and flavor enhancer. According to the UK Federation of Bakers Ltd, the bakery industry is one of the largest segments in the food & beverages sector. Bromelain manufacturers are developing novel products to cater to the increasing demand from the food & beverages industry. For instance, in August 2021, ENZYBEL GROUP, a Belgium-based company, launched a new bromelain product called bromelain K, developed specifically for food & beverages applications such as meat tenderization, protein hydrolyzer, and flavor enhancer.
Bromelain is extensively used as a health supplement in Germany and other Western European countries and is also applied in treating inflammation and swelling of the nose and sinus after an injury or surgery. In addition, bromelain improves functionality and decreases pain in mild acute knee pain and knee osteoarthritis. According to a report by Versus Arthritis, published in early 2023, 10 million people in Europe have osteoarthritis, and 5.4 million people are estimated to have knee osteoarthritis. Such high incidences of orthopedic diseases boost the demand for bromelain-based supplements.
Europe has a well-established personal care industry, and it is one of the most prominent markets for cosmetics and other personal care products. Bromelain-based beauty supplements enhance skin strength and elasticity, thus providing an anti-wrinkle effect to the skin. Bromelain-based skincare products enhance the appearance of dry and damaged skin and are used to treat acne. The improving financial conditions across the region result in increased per capita expenditure on cosmetic and personal care products. According to Cosmetics Europe, an association of personal care product manufacturers, skincare had the most considerable market value among all the categories related to the cosmetics industry in the European Union in 2020. The growing demand for cosmetic products indicates the increasing need for bromelain in Europe.
Europe Bromelain Market Revenue and Forecast to 2030 (US$ Thousand)
Europe Bromelain Market Segmentation
The Europe bromelain market is segmented into source, application, and country.
Based on source, the Europe bromelain market is bifurcated stem and fruit. The stem market segment held a larger share in 2022.
In terms of application, the Europe bromelain market is categorized into food & beverages, pharmaceuticals & nutraceuticals, personal care, and others. The food & beverages segment held the largest share in 2022.
Based on country, the Europe bromelain market is segmented Germany, France, Italy, the UK, Russia, and the Rest of Europe. The Rest of the Europe dominated the Europe bromelain market in 2022.
Challenge Bioproducts Co Ltd, Creative Enzymes, Enzybel International SA, and Medikonda Nutrients are some of the leading companies operating in the Europe bromelain market.
Table of Content